![]() |
Volumn 7, Issue 1, 2010, Pages 1-2
|
Traumatic Brain Injury: Therapeutic Challenges and New Directions
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
CYCLOSPORIN A;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
MAGNESIUM;
PROGESTERONE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ACUTE HEART INFARCTION;
AUSTRALIA;
AXONAL INJURY;
BRAZIL;
CANCER CHEMOTHERAPY;
CHINA;
CLINICAL RESEARCH;
CONTUSION;
DISORDERS OF MITOCHONDRIAL FUNCTIONS;
EDITORIAL;
EUROPE;
FUNDING;
GOVERNMENT;
HIGH THROUGHPUT SCREENING;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPOTHERMIA;
HYPOXIA;
INCIDENCE;
INDIA;
INDUCED HYPOTHERMIA;
INJURY SEVERITY;
INTRACRANIAL PRESSURE;
ISCHEMIA;
JAPAN;
MORBIDITY;
MORTALITY;
NERVE CELL LESION;
NEUROGENIC INFLAMMATION;
NEUROPROTECTION;
NORTH AMERICA;
PREVALENCE;
PRIORITY JOURNAL;
STANDARDIZATION;
STROKE;
SURVIVAL;
TRAUMATIC BRAIN INJURY;
UNITED STATES;
ANIMALS;
BRAIN INJURIES;
CLINICAL TRIALS AS TOPIC;
DISEASE MODELS, ANIMAL;
DRUG DISCOVERY;
HUMANS;
NEUROPROTECTIVE AGENTS;
|
EID: 72949118683
PISSN: 19337213
EISSN: None
Source Type: Journal
DOI: 10.1016/j.nurt.2009.12.001 Document Type: Editorial |
Times cited : (31)
|
References (0)
|